3-(tert-Butoxycarbonyl)-3,7-diazabicyclo[3.3.1]nonane-9-carboxylic acid

Catalog No. :
ACENJY901
CAS No. :
1379794-24-7
Molecular Formula :
C13H22N2O4
Molecular Weight :
270.33

IUPAC Name:3-(tert-butoxycarbonyl)-3,7-diazabicyclo[3.3.1]nonane-9-carboxylic acid

3-(tert-Butoxycarbonyl)-3,7-diazabicyclo[3.3.1]nonane-9-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$754.00Login to see priceInquiryInquiry
250mg98%$1201.00Login to see priceInquiryInquiry
1g98%$3001.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(tert-Butoxycarbonyl)-3,7-diazabicyclo[3.3.1]nonane-9-carboxylic acid
IUPAC Name3-(tert-butoxycarbonyl)-3,7-diazabicyclo[3.3.1]nonane-9-carboxylic acid
MDL No.MFCD22689309
Molecular FormulaC13H22N2O4
Molecular Weight270.33
SMILESO=C(N1CC(C2C(O)=O)CNCC2C1)OC(C)(C)C
InChI KeyPSORKAAJNSNPKZ-UHFFFAOYSA-N
Synonym3,7-Diaza-bicyclo[3.3.1]nonane-3,9-dicarboxylic acid 3-tert-butyl ester;3,7-Diaza-bicyclo3.3.1none-3,9-dicarboxylic acid 3-tert-butyl ester;3-(tert-Butoxycarbonyl)-3,7-diazabicyclo[3.3.1]nonane-9-carboxylic acid;3,7-Diazabicyclo[3.3.1]nonane-3,9-dicarboxylic acid, 3-(1,1-dimethylethyl) ester
CAS No.1379794-24-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACENJY901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACENJY901 route product structure diagram
    ACENJY9011379794-24-7
Inquiry

2. ACENJY901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACENJY901 route product structure diagram
    ACENJY9011379794-24-7
Inquiry

Comments (0)